Purchases and Sales Made in Q4 2022 in Royalty Pharma PLC (RPRX)
This table provides information about the institutional ownership of Royalty Pharma PLC (RPRX) during Q4 2022. The information is specifically focused on institutions that hold shares of Royalty Pharma plc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 13, 2023
Q4 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-560K- 14.18% |
$21.9M - $24.7M
|
3.39M
$82.3M
|
|
Jan 23, 2023
Q4 2022
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-588K- 46.86% |
$23.1M - $25.9M
|
667K
$16.2M
|
|
Jan 24, 2023
Q4 2022
|
Baillie Gifford & CO
|
SELL
|
- |
-749K- 4.19% |
$29.3M - $33M
|
17.1M
$416M
|
|
Feb 14, 2023
Q4 2022
|
Viking Global Investors LP
|
SELL
|
- |
-873K- 8.02% |
$34.2M - $38.5M
|
10M
$243M
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-940K- 1.87% |
$36.8M - $41.4M
|
49.2M
$1.2B
|
|
Feb 14, 2023
Q4 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-1.17M- 14.27% |
$45.6M - $51.3M
|
7M
$170M
|
|
Feb 14, 2023
Q4 2022
|
Capital International Investors
Los Angeles, CA |
SELL
|
- |
-1.17M- 23.35% |
$45.7M - $51.4M
|
3.83M
$93M
|
|
Jan 27, 2023
Q4 2022
|
Siguler Guff Advisers, LLC
|
SELL
|
- |
-3.37M- 49.84% |
$132M - $148M
|
3.39M
$82.4M
|